Concepedia

Arvin Yang

AY

Statistics

Publications

11

Citations

13.1K

H-Index

11

Active since

2000

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Bristol-Myers Squibb (United States)

Dana-Farber Cancer Institute

Cornell University

University of Siena

Arvin Yang is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and immunotherapy.

Top concepts

Publications per year

2000–2017

11

Publications

11

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8K citations · Full text

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Jeffrey S. Weber, Sandra P. D’Angelo, David R. Minor et al. · The Lancet Oncology · 2015 · 2.6K citations

, , +9

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Michael A. Postow, Margaret K. Callahan, Christopher A. Barker et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

, , +17

Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.

Arvin Yang, Edmund C. Lattime · PubMed · 2003 · 164 citations

, , +19

A Blueprint to Advance Colorectal Cancer Immunotherapies

Dung T. Le, Vanessa M. Hubbard-Lucey, Michael A. Morse et al. · Cancer Immunology Research · 2017 · 71 citations · Full text

1–5 of 11